KC7F2

Overview

KC7F2 is a potent hypoxia inducible factor-1 (HIF-1) pathway inhibitor with an IC 50 of 20 μM in LN229-HRE-AP cells, and with potential as a cancer therapy agent.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > HIF/HIF Prolyl-Hydroxylase

Product Information

• Catalog No.: HY-18777
• CAS No.: 927822-86-4
• Molecular Formula: C16H16Cl4N2O4S4
• Molecular Weight: 570.38
• Purity: 99.36%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (4.38 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source